CMAJ earns award nom

The Michener Awards Foundation has nominated the beleaguered Canadian Medical Association Journal (CMAJ) for the linkurl:2005 Michener Award;http://www.michenerawards.ca/english/2005finalists.htm for "meritorious public service journalism." The article that earned the journal their latest nod is the same article at the heart of recent debates over editorial practice at the journal, which has seen the resignations of the majority of editors and editorial board members. The linkurl:inve

Written byAlison McCook
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
The Michener Awards Foundation has nominated the beleaguered Canadian Medical Association Journal (CMAJ) for the linkurl:2005 Michener Award;http://www.michenerawards.ca/english/2005finalists.htm for "meritorious public service journalism." The article that earned the journal their latest nod is the same article at the heart of recent debates over editorial practice at the journal, which has seen the resignations of the majority of editors and editorial board members. The linkurl:investigative article;http://www.cmaj.ca/cgi/rapidpdf/cmaj.051461v1.pdf reported on a screening form designed by the Canadian Pharmacists? Association, in which pharmacists asked personal questions of women buying the emergency contraceptive Plan B, potentially deterring them from the purchase. After the CMAJ published the story, the Ontario Pharmacists? Association said it would not use the form or ask Plan B-buyers personal questions. Who knows how the Canadian Medical Association (CMA), the journal?s publisher, is reacting to the news. For people who have not been in the loop, the saga started on February 20th, when the publisher sacked top editors John Hoey and Anne Marie Todkill after they published the Plan B story. The CMA -- which received complaints about the article from the Canadian Pharmacists? Association and asked Hoey and Todkill to make some changes before it was published -- claimed it fired the editors because it was simply time for a change at the journal's helm. The replacements, Stephen Choi and Sally Murray, linkurl:quit;http://www.the-scientist.com/news/display/23176/ after one week. In the following weeks, the CMA announced linkurl:several measures;http://www.the-scientist.com/news/display/23220/ to strengthen the journal, including establishing a review panel headed by a former Canadian Supreme Court chief justice charged with designing a new governance structure for the CMAJ, and appointing two more top editors. Still, sixteen board members eventually resigned, arguing the CMA was linkurl:not doing enough;http://www.the-scientist.com/news/display/23234/ to ensure the editorial independence of the journal. The latest announcement from the Michener Awards Foundation appears to affirm the public?s support of the CMAJ under Hoey and Todkill, and sends a not-so-subtle message to the CMA. Whether or not the publisher will listen, however, is anyone?s guess.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies